-
Mashup Score: 1
In this quarter’s issue, we are excited to share highlights from our latest public meeting and advocate webinar, along with other important developments we’ve been monitoring in oncology. What’s Happening at Friends?: Catch up on highlights from our recent public meeting and watch our advocate webinar, where experts and advocates discussed groundbreaking work in cellular gene…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet
-
Mashup Score: 4New Analysis Describes Flexibility Associated with Companion Diagnostic Development for Rare Cancer Biomarkers - Friends of Cancer Research - 18 day(s) ago
A new analysis from Friends of Cancer Research (Friends) characterizes flexibilities utilized in the development of companion diagnostics (CDx). Reviewing Summary of Safety and Effectiveness Data (SSED) documents from FDA Premarket Approval applications (PMA) for non-small cell lung cancer (NSCLC), the analysis describes how alternative sample sources can be leveraged for CDx validation, particularly when sample…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Onc News and JournalsTweet-
Attending #DIA2025? Hillary Andrews chairs a panel on validation approaches and regulatory flexibilities for rare biomarker diagnostics, which will discuss strategies for leveraging alternative data sources. Learn more about this work: https://t.co/m6lAqP9nym. https://t.co/XXSKG56UKd
-
-
Mashup Score: 0Digital PATH Project - Friends of Cancer Research - 19 day(s) ago
Digital and Computational Pathology Tool Harmonization Project Quick Links Sign Up for Updates September 2023 White Paper Digital Pathology One Pager Project Outcomes The Digital and Computational Pathology Tool Harmonization (Digital PATH) Project, led by Friends of Cancer Research (Friends), supports robust development of digital and computational pathology platforms for use in oncology drug development…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Onc News and JournalsTweet-
Friends is leading a new research partnership, the Digital PATH Project, to support robust development of digital and computational pathology platforms for use in oncology drug development. View our project page here: https://t.co/enyHmiO2C6 https://t.co/fgIEj4GrM5
-
-
Mashup Score: 2Data-Driven Insights | 30+ Years of Accelerated Approval: Trends, Timelines, and Impact - Friends of Cancer Research - 24 day(s) ago
Introduction and Background The Accelerated Approval (AA) program is a drug development pathway that was established to expedite the delivery of promising treatments to patients, primarily for serious and life-threatening conditions. AA is granted based on surrogate endpoints, such as tumor size reduction in cancer patients, that are reasonably likely to predict clinical benefit. These…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
Is the @US_FDA Accelerated Approval pathway working as intended? Our analysis of all 344 approvals shows most treatments are verified, confirmatory trials progress on track, and clinical benefit is confirmed within four years. Explore our full analysis https://t.co/NXVXO4a3Xh https://t.co/cvWjMt7ptz
-
-
Mashup Score: 4Meeting Recap | Unlocking Next-Generation Therapies Meeting Recap: Sharing Next Steps and Opportunities with Advocates - Friends of Cancer Research - 1 month(s) ago
On February 4th, Friends of Cancer Research (Friends) hosted a public meeting, “Advancing the Future of Diagnostics and Regulatory Innovations,” emphasizing the dual objectives of ensuring patient safety while fostering an environment conducive to innovation—a balance that is becoming increasingly critical in an era marked by rapid technological advancements.
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
Read the recap of our #patientadvocate webinar of the "Next Generation Therapies" meeting to learn policy opportunities that overcome current barriers and ensure that patients can access the potentially transformative benefits of #celltherapies: https://t.co/Zde7e84tLD. https://t.co/1DL60kRUvm
-
-
Mashup Score: 2Data-Driven Insights | 30+ Years of Accelerated Approval: Trends, Timelines, and Impact - Friends of Cancer Research - 1 month(s) ago
Introduction and Background The Accelerated Approval (AA) program is a drug development pathway that was established to expedite the delivery of promising treatments to patients, primarily for serious and life-threatening conditions. AA is granted based on surrogate endpoints, such as tumor size reduction in cancer patients, that are reasonably likely to predict clinical benefit. These…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
Is the @US_FDA Accelerated Approval pathway working as intended? Our analysis of all 344 approvals shows most treatments are verified, confirmatory trials progress on track, and clinical benefit is confirmed within four years. Explore our full analysis https://t.co/NXVXO4a3Xh https://t.co/cvWjMt7ptz
-
-
Mashup Score: 0Unlocking Next-Generation Therapies Meeting Recap: Sharing Next Steps and Opportunities with Advocates - Friends of Cancer Research - 2 month(s) ago
Wednesday, May 21, 2025 12PM – 1PM ET Online (Zoom) Register Today What are some challenges impeding the broad development of engineered cell-based therapies? Friends of Cancer Research (Friends) is hosting a webinar designed for advocates on May 21, 2025, as a follow-up to the public meeting hosted by Friends’ and the Parker Institute for…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
Using engineered T-cells, scientists have created therapies that better detect and treat #cancer. Watch our video to learn about CAR-T #celltherapies and join fellow patient advocates on May 21 to explore how manufacturing challenges impact patient access. https://t.co/D3SMT1SyIf https://t.co/JQF2iuC6nq
-
-
Mashup Score: 0Unlocking Next-Generation Therapies Meeting Recap: Sharing Next Steps and Opportunities with Advocates - Friends of Cancer Research - 2 month(s) ago
Wednesday, May 21, 2025 12PM – 1PM ET Online (Zoom) Register Today What are some challenges impeding the broad development of engineered cell-based therapies? Friends of Cancer Research (Friends) is hosting a webinar designed for advocates on May 21, 2025, as a follow-up to the public meeting hosted by Friends’ and the Parker Institute for…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
Using engineered T-cells, scientists have created therapies that better detect and treat #cancer. Watch our video to learn about CAR-T #celltherapies and join fellow patient advocates on May 21 to explore how manufacturing challenges impact patient access. https://t.co/D3SMT1SyIf https://t.co/JQF2iuC6nq
-
-
Mashup Score: 13Lung-MAP Advocacy Webinar: Advocating, Accelerating, and Amplifying Lung Cancer Discovery - Friends of Cancer Research - 2 month(s) ago
Wednesday, May 14th 1:00PM – 2:00PM ET Virtual Webinar Register here The Lung-MAP Accrual Enhancement Committee (AEC) is hosting an upcoming public webinar titled, Advocating, Accelerating, and Amplifying Lung Cancer Discovery. The webinar will feature experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
The @LungMAP Accrual Enhancement Committee is hosting the "Advocating, Accelerating, and Amplifying Lung Cancer Discovery" webinar on May 14. Learn about clinical trial updates, Lung-MAP's advantages, and patient engagement opportunities. Register today: https://t.co/woKVtykcL8 https://t.co/MsXLHEAFvM
-
-
Mashup Score: 13Lung-MAP Advocacy Webinar: Advocating, Accelerating, and Amplifying Lung Cancer Discovery - Friends of Cancer Research - 2 month(s) ago
Wednesday, May 14th 1:00PM – 2:00PM ET Virtual Webinar Register here The Lung-MAP Accrual Enhancement Committee (AEC) is hosting an upcoming public webinar titled, Advocating, Accelerating, and Amplifying Lung Cancer Discovery. The webinar will feature experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP…
Source: friendsofcancerresearch.orgCategories: General Medicine NewsTweet-
The @LungMAP Accrual Enhancement Committee is hosting the "Advocating, Accelerating, and Amplifying Lung Cancer Discovery" webinar on May 14. Learn about clinical trial updates, Lung-MAP's advantages, and patient engagement opportunities. Register today: https://t.co/woKVtykcL8 https://t.co/MsXLHEAFvM
-
#PatientAdvocates, your Q2 Advocate Newsletter is here! Get highlights from our recent conference, trends in Accelerated Approval and breaking news in cancer research. Read the latest issue and subscribe to stay up to date on cancer advocacy and research: https://t.co/Xr2GDePscX. https://t.co/5VaPMQPdvJ